By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



29 Newbury Street

Boston  Massachusetts  02116  U.S.A.
Phone: 617-236-0535 Fax: 617-249-0490


Start Up

Company News
Zafgen (ZFGN) Reports Second Quarter 2015 Financial Results 8/12/2015 11:15:03 AM
Zafgen (ZFGN) To Present At Canaccord Genuity 35th Annual Growth Conference 2015 8/6/2015 2:56:30 PM
Zafgen (ZFGN) To Host Conference Call to Discuss Second Quarter 2015 Financial Results 8/5/2015 10:19:04 AM
Zafgen (ZFGN) To Present At JMP Securities Life Sciences Conference 2015 6/18/2015 8:00:07 AM
Zafgen (ZFGN) To Present At 2015 BIO International Convention 6/11/2015 8:29:22 AM
Zafgen (ZFGN) Completes Enrollment Of U.S. Phase III Trial Of Beloranib In Prader-Willi Syndrome 5/28/2015 6:41:21 AM
Zafgen (ZFGN) Appoints Global Head Of Medical Affairs And Global Head Of Regulatory 5/27/2015 7:11:19 AM
Zafgen (ZFGN) Reports First Quarter 2015 Financial Results 5/13/2015 8:51:57 AM
Zafgen (ZFGN) Presents Positive Safety And Efficacy Data From Phase II Trial Of Beloranib In Severe Obesity And Proof Of Concept Trial In Prader-Willi Syndrome At ECO 2015 5/8/2015 8:06:13 AM
Zafgen (ZFGN) Announces Oral And Poster Presentations At The 22nd European Congress On Obesity 5/7/2015 12:39:59 PM